Good point Csnody....,
The golden rule of thumb procedure, if the cause is undetermined or in the event of FDA re commencement approval on the ptx200, is that of an 'outlier'.
That is, no significant skew effect with an outlier due to omission in data pack.
Hope this helps.
- Forums
- ASX - By Stock
- Ann: Clinical Trial Update
Good point Csnody...., The golden rule of thumb procedure, if...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.21M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 4.0¢ | $22.35K | 558.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 221774 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 860576 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 249700 | 0.043 |
3 | 145000 | 0.042 |
6 | 477461 | 0.041 |
7 | 247800 | 0.040 |
3 | 130000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 99540 | 2 |
0.047 | 18686 | 2 |
0.048 | 200000 | 1 |
0.049 | 194091 | 3 |
0.050 | 427445 | 9 |
Last trade - 14.51pm 19/11/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |